Mid-Cap

Five stocks you should have bought earlier and held on to

September 08, 2016 | Team Kalkine
Five stocks you should have bought earlier and held on to


 
Flight Centre Travel Group Ltd


FLT Details

Online TTV expected to exceed $1billion for FY17:Flight Centre Travel Group Ltd (ASX: FLT) has reported a 9.7% increase in TTV globally to $19.3 billion in FY 16. The revenue increased 11.2% to $2.7 billion, leading to an improved income margin of 13.8%. The underlying net profit after tax (NPAT) is $246.7 million, down 3.8%, while statutory NPAT decreased 4.7% to $244.6 million. FLT has also unveiled a number of strategic initiatives, including plans to fast-track growth in six key sectors globally. Moreover, FLT intends to significantly expand online during FY17 which would see them develop a global online presence by launching transactional websites in Europe, Asia, the UAE and South Africa in FY 17 to complement and enhance the existing online businesses in Australia, the Americas and New Zealand. The Online TTV for FY17 is expected to exceed $1 billion.
 

FY 16 Financial Performance (Source: Company Reports)
 
In addition, FLT’s customers will benefit from interest-free finance through FlexiGroup’s wholly owned subsidiary, Lombard Finance Pty Limited on their travel purchases. Initially, FlexiGroup would make an investment of around $3 million in FY17 for this. Trading at a reasonable dividend yield and a decent P/E, we give a “Hold” recommendation on the stock at the current price of $36.52
 

FLT Daily Chart (Source: Thomson Reuters)
 
Bellamy’s Australia Ltd


BAL Details

Strong EBIT growth in FY 16: Bellamy's Australia Ltd (ASX: BAL) reported an EBIT growth of 342% to $54.3 m in FY 16, while the revenue grew 95% to $245 m. China’s revenues surged 331% while NPAT grew by 326% to $38.3 m.  The EBIT margin has more than doubled from 10% in FY15 to 22% in FY16.
 

FY 16 Financial Performance (Source: Company Reports)
 
Moreover, BAL has strong cost management driven by the growth in the business infrastructure as the head count has increased by 50%. BAL intends to continue to invest in its supply chain and other initiatives to drive sustainable growth and further optimize long term returns. Meanwhile, BAL stock has risen 36.08% in the last six months (as of September 07, 2016), and we give a “Hold” recommendation on the stock at the current price of $13.45
 

BAL Daily Chart (Source: Thomson Reuters)
 
SEEK Limited


SEK Details

Exceeded NPAT guidance in FY 16:SEEK Limited (ASX: SEK) reported underlying NPAT of A$198.1m in FY 16 exceeding the NPAT guidance. SEK for Australia and New Zealand Employment has reported a revenue growth & EBITDA growth of 15% considering the benign economy.
 

Growth of Market Opportunity (Source: Company Reports)
 
For the International, SEK’s revenue grew 18% and EBITDA grew 17%. The group also reported for 11% growth in dividends. Since IPO, the total shareholder returns delivered by the company are of the order of 809% against 126% by ASX 200. We give a “Hold” recommendation on the stock at the current price of $15.62
 

SEK Daily Chart (Source: Thomson Reuters)
 
CSL Ltd


CSL Details

Weak bottom line drove the stock lower: CSL Limited (ASX: CSL) has announced that the US Food and Drug Administration (FDA) has accepted for review of CSL Behring’s Biologics License Application (BLA) for its low-volume subcutaneous (SC) C1-Esterase Inhibitor (C1-INH) Human replacement therapy, CSL830, as prophylaxis to prevent Hereditary Angioedema (HAE) attacks. On the other hand, CSL net profit after tax (NPAT) fell 11% year on year (yoy) to US$1,242 million in FY 16 due to acquisition costs of Novartis vaccine. After excluding the Novartis influenza vaccines business financials (acquired in FY 16), the underlying NPAT grew 5% and underlying earnings per share (EPS) grew 7% on a constant currency basis. However, given this weak bottom line, CSL stock fell over 10.61% in the last four weeks (as of September 07, 2016), and is still trading at a higher P/E. However, the group expects to grow its NPAT by 11% for FY17 at constant currency. Based on the foregoing, we give an “Expensive” recommendation on the stock at the current price of $103.72
 

CSL Daily Chart (Source: Thomson Reuters)
 
REA Group Ltd


REA Details

Acquired iProperty group and Flatmates: REA Group Ltd (ASX: REA) has reported a solid 20% increase in revenue to $630m and 16% increase in NPAT to $215m in FY 16 as compared to FY 15 for core operations. Moreover, the group’s core business, realestate.com.au is still number one, and REA is constantly gaining penetration by acquiring iProperty group and Flatmates.
 

FY 16 Financial Performance (Source: Company Reports)
 
There has been an 81% app visits growth on yoy basis. Meanwhile, REA stock has risen 12.73% in the last six months (as of September 07, 2016), and we believe that there is potential in the stock. Based on the foregoing, we give a “Hold” recommendation on the stock at the current price of $55.97
 

REA Daily Chart (Source: Thomson Reuters)




Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376).The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd currently hold positions in:  BHP, BKY, KCN, PDN, and RIO. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.